NEW YORK (GenomeWeb) – Molecular diagnostics developer Castle Biosciences said today that it has expanded its credit facility with Silicon Valley Bank to $14 million.

The new facility refinances the company's existing $6 million loan, and adds $2 million in capital for new growth and a $5 million accounts receivable revolver loan. Castle said it will use the money to accelerate the development of its cutaneous melanoma test, DecisionDx-Melanoma, and to speed up new projects in its molecular diagnostic pipeline.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.